PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Those who view TV and social media as trustworthy sources of COVID news -- less informed

2021-04-12
(Press-News.org) People who trust television and Facebook to provide them with accurate news about the coronavirus pandemic are less knowledgeable about COVID-19, according to a new study, which assessed people's knowledge of the virus in the earliest stages of the pandemic.

The study, published today in the peer-reviewed journal END


ELSE PRESS RELEASES FROM THIS DATE:

Study finds rapid evolution in foxgloves pollinated by hummingbirds

2021-04-12
Researchers have found common foxgloves brought to the Americas have rapidly evolved to change flower length in the presence of a new pollinator group, hummingbirds. The findings are published in the British Ecological Society's Journal of Ecology. Researchers from the University of Sussex, Universidad de Los Andes (Colombia) and Universidad de Costa Rica, studying the common foxglove Digitalis purpurea, a bumblebee pollinated species native to Europe, have shown for the first time how rapid physical changes can occur in flowers following a change in environment and the presence of a new pollinator. The researchers compared foxgloves in the UK, which ...

Study shows tanning bed ban would reduce skin cancer rates in minors and cut healthcare costs

2021-04-12
A recent study indicates that a U.S. ban on the use of tanning beds among minors would prevent thousands of cases of melanoma in adolescents and would save millions of dollars in healthcare costs. The findings are published early online in END ...

Workplace study during pandemic finds managers should talk less, listen more

2021-04-12
Workplace communication often took a back seat this past year, as employees and employers rushed to work remotely, struggled with technology barriers and adjusted to physical distancing. But the pandemic has resulted in valuable lessons for communicating on the job, according to a Baylor University study. During the onset of COVID-19 -- along with accompanying layoffs and a recession -- "there likely has never been a moment with such demand for ethical listening to employees," said lead author Marlene S. Neill, Ph.D., associate professor of journalism, public relations and new media at Baylor. "Ethical listening" was defined by one communication ...

Shift in diet allowed gray wolves to survive ice-age extinction

Shift in diet allowed gray wolves to survive ice-age extinction
2021-04-12
April12, 2021 - Gray wolves are among the largest predators to have survived the extinction at the end of the last ice age around11,700 years ago. Today, they can be found roaming Yukon's boreal forest and tundra, with caribou and moose as their main sources of food. A new study led by the Canadian Museum of Nature shows that wolves may have survived by adapting their diet over thousands of years---from a primary reliance on horses during the Pleistocene, to caribou and moose today. The results are published in the journal Palaeogeography, Palaeoclimatology, Palaeoecology. The research team, led by museum palaeontologist Dr. Danielle Fraser and student Zoe Landry, analysed evidence preserved in ...

MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021

MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
2021-04-11
HOUSTON -- Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with RET fusion-positive cancers, high-grade (HGG) and low-grade glioma (LGG) and ovarian cancer. The results, presented today at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, showcase the researchers' ongoing efforts to advance clinical studies and expand potential indications of approved drugs to develop a platform for more effective treatments and to improve patient outcomes. FDA-approved selpercatinib shows clinical benefits for RET fusion-positive ...

Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer

2021-04-10
PHILADELPHIA--Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania. Changing the microenvironment from so-called T cell "poor" to T cell "rich" with a CD40 agonist earlier could help slow eventual progression of the disease and prevent cancer from spreading in more patients. The data--which included 16 ...

New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin's B-cell lymphoma

2021-04-10
LOS ANGELES -- Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimizes treatment resistance, resulting in long-lasting remission for people with non-Hodgkin's B-cell lymphoma that has come back or has not responded to treatment. The new approach, which will be presented at the American Association for Cancer Research Annual Meeting during one of the clinical oral plenary sessions ( END ...

Personalized cancer vaccine is safe, shows potential benefit against cancer

2021-04-10
New York, NY (April 10, 2021) - A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15. "While immunotherapy has revolutionized the treatment of cancer, the vast majority of patients do not experience a significant clinical response with such treatments," said study author Thomas Marron, MD, PhD, Assistant Director for Early Phase and Immunotherapy Trials ...

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
2021-04-10
HOUSTON - Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact through the CREB1 protein to promote metastasis and tumor growth. Blocking CREB1 in preclinical models reversed these effects and reduced metastases, suggesting an important new therapeutic target for the deadly cancer. The findings were published today in Cancer Discovery and presented at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021 by Michael Kim, M.D., ...

The impact of chemotherapy on immune cells in the tumor microenvironment

2021-04-10
Research from Queen Mary University of London has revealed novel insights into the effects of chemotherapy on the tumour microenvironment (TME). The study, published today in Cancer Immunology Research, a journal of the American Association for Cancer Research, found that chemotherapy enhances the anti-tumour actions of immune cells within the TME and their ability to support immune responses against cancer. Cancers are not just a mass of cancerous cells, but are rogue organs made up of many different cell types, including cells that form connective tissue and blood vessels, and immune cells. These non-cancerous cells have been recruited and corrupted by the cancer to help it grow and spread, and constitute what ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Those who view TV and social media as trustworthy sources of COVID news -- less informed